In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Hold rating on GoHealth (GOCO – Research Report), with a price target of $13.00. The company’s shares closed last Friday at $9.01.
According to TipRanks, Hendrix is a 4-star analyst with an average return of 5.1% and a 57.28% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Brookdale Senior Living, and Community Health.
Currently, the analyst consensus on GoHealth is a Moderate Buy with an average price target of $17.50.
Based on GoHealth’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $132.04 million and a GAAP net loss of $23.91 million. In comparison, last year the company earned a revenue of $133.05 million and had a GAAP net loss of $30.01 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
GoHealth (GOCO) Company Description:
GoHealth Inc is a health insurance marketplace in America. Its technology platform leverages modern machine-learning algorithms and helps individuals find the best health insurance plan for their specific needs. The company operates in four segments: Medicare-Internal; Medicare-External, IFP and Other-Internal; and IFP and Other-External. The Medicare segments sales Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans.
Read More on GOCO:
- GoHealth reports Q1 EPS ($1.04), consensus (95c)
- Upcoming Deadline to Share in GoHealth, Inc. (GOCO) Class Action Settlement
- GoHealth to Present at the LD Micro Invitational XIV
- GoHealth price target lowered to $13 from $20 at RBC Capital
- GoHealth sees 2024 revenue flat, operating cash flow flat to slightly up
